WEBULL
WebtradeDownload

UnitedHealth Group (UNH) Could Be 22% Undervalued After 2026 Guidance Lift

Simply Wall St · 2d ago

UnitedHealth Group (UNH) moved back into focus after raising its full year 2026 earnings guidance, lifting expected diluted EPS to at least US$19.50 on net income above US$17.65b.

Recent trading tells a mixed story. UnitedHealth Group’s share price is up 12.29% year to date, while the 1-year total shareholder return is 7.75%. However, a 25.04% decline in 3-year total shareholder return shows longer term momentum has faded despite the guidance hike and stronger recent earnings.

See how UnitedHealth Group’s guidance reset compares with peers by reviewing a hand-picked 33 healthcare AI stocks shaping the next phase of tech-enabled healthcare.

UnitedHealth Group now trades at a steep discount to both analyst targets and some intrinsic value estimates after this guidance reset. Is that a genuine pricing opportunity, or a sign that the market still sees real risk?

Most Popular Narrative: 22% Undervalued

UnitedHealth Group’s most followed valuation narrative places fair value at $481.72, well above the last close of $377.76. This frames today’s discount as a bet on execution rather than a technical anomaly.

The main thing that has to go right is execution on margin recovery in Medicare, Medicaid and commercial lines, along with delivering the OptumHealth turnaround and AI-enabled cost savings in the face of elevated medical trends and regulatory scrutiny.

See why 667 investors see UnitedHealth Group as 22% undervalued.

Result: Fair Value of $481.72 (UNDERVALUED)

Still, UnitedHealth Group faces pressure from higher commercial medical costs and weaker Medicaid margins, either of which could blunt the margin recovery that investors are counting on.

Find out about the key risks to this UnitedHealth Group narrative.

Next Steps

Mixed sentiment on UnitedHealth Group’s reset is evident. Review the full picture quickly and weigh both the 5 key rewards and 1 important warning sign.

Looking for more investment ideas beyond UnitedHealth Group?

If UnitedHealth Group has you rethinking your portfolio mix, now is the moment to widen your search before the next wave of opportunities passes you by.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.